SCHEMBL4697200

SCHEMBL4697200

O=C(CNCCOC(=O)N(c1ccccc1-c1ccccc1)N1CC[CH]CC1)c1ccc(CNCC2CC2)cc1

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.37
HDAC3 O15379 2/20 0.37
HDAC6 Q9UBN7 2/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37
HDAC5 Q9UQL6 1/20 0.37
PDCD1 Q15116 2/20 0.35
CD274 Q9NZQ7 2/20 0.35
CXCR4 P61073 1/20 0.33
ALDH1A1 P00352 3/20 0.32
KMT2A Q03164 2/20 0.32
FSHR P23945 1/20 0.32
LMNA P02545 1/20 0.32
MEN1 O00255 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4696335 0.91 PDCD1 (0.44) PDCD1CD274ALDH1A1
SCHEMBL4692560 0.89 CD274 (0.39) HDAC1PDCD1CD274
SCHEMBL4691952 0.89 PDCD1 (0.35) PDCD1CD274ALDH1A1LMNA
SCHEMBL4695736 0.88 ALDH1A1 (0.40) HDAC1HDAC6ALDH1A1LMNA
SCHEMBL4695511 0.88 PDCD1 (0.34) HDAC1PDCD1CD274
SCHEMBL6027383 0.87 OPRM1 (0.36) HDAC1PDCD1CD274ALDH1A1KMT2A
SCHEMBL4696628 0.85 HDAC1 (0.35) HDAC1HDAC3HDAC6HDAC4HDAC7
SCHEMBL12505524 0.85 ALDH1A1 (0.34) ALDH1A1
SCHEMBL4695176 0.85 POLB (0.37) HDAC1HDAC3HDAC6HDAC4HDAC7
SCHEMBL4694768 0.85 HDAC1 (0.36) HDAC1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893577-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS Theravance, Inc. (US) 2008-03-05 EP disclosed
WO-2006138218-A1 BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS THERAVANCE, INC. (US) 2006-12-28 WO disclosed